Flipped Autograft for Treating Surgical Wound Dehiscence

Flipped Autograft: a Novel Approach for Management of Wound Dehiscence in Implant Dentistry

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05513222

Enrollment

Registered

2022-08-24

Start date

2021-07-22

Completion date

2022-04-27

Last updated

2024-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Dehiscence

Brief summary

This case report describes a novel technique for management of peri-implant wound dehiscence that involves using auto graft from the same surgical site to seal the dehiscence defect.

Interventions

PROCEDUREflipped autograft

Thick lingual flap was de-epithelized and partially dissected to increase its length then flipped and sutured to the buccal flap to obtain primary closure

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

1. Adult patients in a healthy systemic condition. 2. Both genders 3. Patients should have single missing tooth. 4. Seibert Class I ridge defect. 5. Patients should approve to deliver a signature to a written consent after study nature explanation.

Exclusion criteria

* 1- Patients with any smoking habits. 2- Pregnant females, decisional impaired individuals, Prisoners and handicapped patients. 3- Patients having poor oral hygiene or not wanting to carry out oral hygiene measures. 4- Patients with infections either periodontally or periapically.

Design outcomes

Primary

Measure	Time frame	Description
complete primary intention healing of the wound dehiscence	3 months	complete uneventful healing will be assessed clinically by measuring soft tissue width and thickness using periodontal probe under local anesthesia

Secondary

Measure	Time frame	Description
esthetic outcome and patient satisfaction.	3 months	esthetic outcome will be measured using pink esthetic score. Pink esthetic score (PES) will be recorded for five variables: mesial papilla, distal papilla, curvature of the facial mucosa, level of the facial mucosa, and root convexity/soft tissue color and texture at the facial aspect of the implant site. A score of 2, 1, or 0 will be assigned to all five parameters. also patient satisfaction will be recorded using: • (VAS) Visual analogue scale to measure postoperative pain. Pain score reported by the patient. directly through Visual Analogue Scale score (from 0 to 10. 0: no pain, 1: minimal pain, 5: moderate pain, 10: severe pain) which will be recorded after 2 weeks (Yildirim et al., 2017)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026